Company profile for AskBio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Founded in 2001, Asklepios BioPharmaceutical, Inc. (AskBio) is a privately held, clinical-stage gene therapy company dedicated to improving the lives of children and adults with genetic disorders. AskBio’s gene therapy platform includes an industry-leading proprietary cell line manufacturing process called Pro10™ and an extensive adeno-associated virus (AAV) capsid and promoter library. Based in Research Triangle Park, Nor...
Founded in 2001, Asklepios BioPharmaceutical, Inc. (AskBio) is a privately held, clinical-stage gene therapy company dedicated to improving the lives of children and adults with genetic disorders. AskBio’s gene therapy platform includes an industry-leading proprietary cell line manufacturing process called Pro10™ and an extensive adeno-associated virus (AAV) capsid and promoter library. Based in Research Triangle Park, North Carolina, the company has generated hundreds of proprietary third-generation AAV capsids and promoters, several of which have entered clinical testing.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
20 T.W. Alexander Drive Suite 110 Research Triangle Park, NC 27709
Telephone
Telephone
+1 (919) 561-6210
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/21/3170137/0/en/AskBio-Announces-Publication-in-Nature-Medicine-of-12-month-data-from-Phase-1-Trial-of-AB-1002-Gene-Therapy-in-Participants-with-Congestive-Heart-Failure.html

GLOBENEWSWIRE
21 Oct 2025

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bayers-gene-and-cell-therapy-pipeline-aims-to-transform-parkinsons-oncology-rare-diseases-and-more/articleshow/124529407.cms

ECONOMICTIMES
13 Oct 2025

https://www.globenewswire.com/news-release/2025/10/10/3164826/0/en/AskBio-Presents-Interim-Safety-Results-from-Phase-1-Phase-2-LION-CS101-Clinical-Trial-of-AB-1003-in-Participants-with-Limb-Girdle-Muscular-Dystrophy-2I-R9.html

GLOBENEWSWIRE
10 Oct 2025

https://www.globenewswire.com/news-release/2025/10/02/3160314/0/en/AskBio-Announces-6-Presentations-at-the-European-Society-of-Gene-and-Cell-Therapy-32nd-Annual-Meeting.html

GLOBENEWSWIRE
02 Oct 2025

https://www.globenewswire.com/news-release/2025/09/22/3153736/0/en/First-European-Participants-Randomized-in-AskBio-Phase-2-Gene-Therapy-Trial-of-AB-1005-for-Parkinson-s-Disease.html

GLOBENEWSWIRE
22 Sep 2025

https://www.globenewswire.com/news-release/2025/05/27/3088653/0/en/AskBio-Announces-Publication-of-Complete-Results-of-Phase-1b-Trial-of-AB-1005-Gene-Therapy-in-Participants-with-Parkinson-s-Disease-in-Movement-Disorders.html

GLOBENEWSWIRE
27 May 2025

ABOUT THIS PAGE

Contact AskBio and get a quotation

AskBio is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of RECOMBINANT ADENO-ASSOCIATED VIRUS (RAAV) bulk offered by AskBio

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty